Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyOther or not reported

Hydrogen-Rich Saline Activated Autophagy via HIF-1α Pathways in Neuropathic Pain Model.

Huixing Wang, Xiaodong Huo, Hongguang Chen, Bo Li, Jingzhi Liu, Wenting Ma, Xiaojuan Wang, Keliang Xie, Yonghao Yu, Kemei Shi · BioMed research international · 2018

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Molecular Hydrogen Overview
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In Sprague-Dawley rats, hRS improved MWT and TWL, activated autophagy, and increased autophagosomes and autolysosomes in CCI rats. These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.

What the Researchers Studied

Hydrogen-rich saline (HRS) reportedly reduces allodynia and hyperalgesia in a neuropathic pain model; however, it is unknown whether these effects involve autophagy induction.

What the Researchers Found

HRS improved MWT and TWL, activated autophagy, and increased autophagosomes and autolysosomes in CCI rats.

Authors’ Conclusion

The authors concluded that hRS reduced mechanical hyperalgesia and activation of cell autophagy in neuropathic pain through a HIF1-dependent pathway. These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.